25 XP   0   0   10

Uniqure NV
Buy, Hold or Sell?

Let's analyse Uniqure together

PenkeI guess you are interested in Uniqure NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Uniqure NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Uniqure NV

I send you an email if I find something interesting about Uniqure NV.

Quick analysis of Uniqure (30 sec.)










What can you expect buying and holding a share of Uniqure? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.34
Expected worth in 1 year
$-1.27
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-5.61
Return On Investment
-123.6%

For what price can you sell your share?

Current Price per Share
$4.54
Expected price per share
$0 - $6.87
How sure are you?
50%

1. Valuation of Uniqure (5 min.)




Live pricePrice per Share (EOD)

$4.54

Intrinsic Value Per Share

$-20.99 - $-16.46

Total Value Per Share

$-16.65 - $-12.12

2. Growth of Uniqure (5 min.)




Is Uniqure growing?

Current yearPrevious yearGrowGrow %
How rich?$207.6m$482.4m-$171.7m-55.3%

How much money is Uniqure making?

Current yearPrevious yearGrowGrow %
Making money-$77.1m-$31.6m-$45.4m-58.9%
Net Profit Margin-2,934.5%-3,440.1%--

How much money comes from the company's main activities?

3. Financial Health of Uniqure (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#245 / 1010

Most Revenue
#372 / 1010

Most Profit
#944 / 1010

Most Efficient
#871 / 1010

What can you expect buying and holding a share of Uniqure? (5 min.)

Welcome investor! Uniqure's management wants to use your money to grow the business. In return you get a share of Uniqure.

What can you expect buying and holding a share of Uniqure?

First you should know what it really means to hold a share of Uniqure. And how you can make/lose money.

Speculation

The Price per Share of Uniqure is $4.54. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Uniqure.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Uniqure, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.34. Based on the TTM, the Book Value Change Per Share is $-1.40 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.63 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Uniqure.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.53-33.7%-1.61-35.5%-0.66-14.6%-0.37-8.2%-0.49-10.7%
Usd Book Value Change Per Share-1.28-28.1%-1.40-30.9%-0.63-13.8%0.030.6%0.102.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.28-28.1%-1.40-30.9%-0.63-13.8%0.030.6%0.102.3%
Usd Price Per Share6.77-11.27-19.54-32.74-24.91-
Price to Earnings Ratio-1.11--1.78-6.20--36.34--23.42-
Price-to-Total Gains Ratio-5.30--8.39--6.58--24.34--19.37-
Price to Book Ratio1.56-1.66-1.96-6.06-9.88-
Price-to-Total Gains Ratio-5.30--8.39--6.58--24.34--19.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.54
Number of shares220
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.400.03
Usd Total Gains Per Share-1.400.03
Gains per Quarter (220 shares)-308.516.45
Gains per Year (220 shares)-1,234.0425.81
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1234-124402616
20-2468-247805242
30-3702-371207768
40-4936-4946010394
50-6170-61800129120
60-7404-74140155146
70-8638-86480181172
80-9872-98820206198
90-11106-111160232224
100-12340-123500258250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%3.09.00.025.0%3.017.00.015.0%4.036.00.010.0%4.041.00.08.9%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%5.015.00.025.0%11.026.03.027.5%12.029.04.026.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.045.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%5.015.00.025.0%11.026.03.027.5%12.029.04.026.7%

Fundamentals of Uniqure

About Uniqure NV

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease. In addition, it is developing AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands.

Fundamental data was last updated by Penke on 2024-04-12 16:12:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Uniqure NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Uniqure earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Uniqure to the Biotechnology industry mean.
  • A Net Profit Margin of -1,094.4% means that $-10.94 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Uniqure NV:

  • The MRQ is -1,094.4%. The company is making a huge loss. -2
  • The TTM is -2,934.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,094.4%TTM-2,934.5%+1,840.1%
TTM-2,934.5%YOY-3,440.1%+505.6%
TTM-2,934.5%5Y-3,831.9%+897.4%
5Y-3,831.9%10Y-2,251.3%-1,580.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,094.4%-207.2%-887.2%
TTM-2,934.5%-216.8%-2,717.7%
YOY-3,440.1%-282.3%-3,157.8%
5Y-3,831.9%-436.8%-3,395.1%
10Y-2,251.3%-597.3%-1,654.0%
1.1.2. Return on Assets

Shows how efficient Uniqure is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Uniqure to the Biotechnology industry mean.
  • -8.8% Return on Assets means that Uniqure generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Uniqure NV:

  • The MRQ is -8.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.8%TTM-9.6%+0.8%
TTM-9.6%YOY-4.6%-5.1%
TTM-9.6%5Y-4.6%-5.1%
5Y-4.6%10Y-6.9%+2.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.8%-13.3%+4.5%
TTM-9.6%-12.8%+3.2%
YOY-4.6%-11.6%+7.0%
5Y-4.6%-13.8%+9.2%
10Y-6.9%-15.6%+8.7%
1.1.3. Return on Equity

Shows how efficient Uniqure is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Uniqure to the Biotechnology industry mean.
  • -35.3% Return on Equity means Uniqure generated $-0.35 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Uniqure NV:

  • The MRQ is -35.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -26.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-35.3%TTM-26.7%-8.6%
TTM-26.7%YOY-6.6%-20.0%
TTM-26.7%5Y-10.2%-16.5%
5Y-10.2%10Y-19.6%+9.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-35.3%-16.9%-18.4%
TTM-26.7%-16.1%-10.6%
YOY-6.6%-14.9%+8.3%
5Y-10.2%-19.3%+9.1%
10Y-19.6%-20.1%+0.5%

1.2. Operating Efficiency of Uniqure NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Uniqure is operating .

  • Measures how much profit Uniqure makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Uniqure to the Biotechnology industry mean.
  • An Operating Margin of -816.0% means the company generated $-8.16  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Uniqure NV:

  • The MRQ is -816.0%. The company is operating very inefficient. -2
  • The TTM is -2,691.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-816.0%TTM-2,691.5%+1,875.6%
TTM-2,691.5%YOY-4,694.5%+2,003.0%
TTM-2,691.5%5Y-4,337.9%+1,646.3%
5Y-4,337.9%10Y-2,482.0%-1,855.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-816.0%-298.0%-518.0%
TTM-2,691.5%-238.5%-2,453.0%
YOY-4,694.5%-288.4%-4,406.1%
5Y-4,337.9%-486.2%-3,851.7%
10Y-2,482.0%-628.4%-1,853.6%
1.2.2. Operating Ratio

Measures how efficient Uniqure is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 10.23 means that the operating costs are $10.23 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Uniqure NV:

  • The MRQ is 10.231. The company is inefficient in keeping operating costs low. -1
  • The TTM is 28.055. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ10.231TTM28.055-17.824
TTM28.055YOY46.949-18.893
TTM28.0555Y47.604-19.549
5Y47.60410Y30.074+17.530
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.2313.235+6.996
TTM28.0553.310+24.745
YOY46.9493.838+43.111
5Y47.6045.679+41.925
10Y30.0747.823+22.251

1.3. Liquidity of Uniqure NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Uniqure is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.85 means the company has $8.85 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Uniqure NV:

  • The MRQ is 8.848. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.176. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.848TTM9.176-0.328
TTM9.176YOY9.330-0.154
TTM9.1765Y10.744-1.568
5Y10.74410Y8.809+1.935
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.8483.863+4.985
TTM9.1764.169+5.007
YOY9.3305.337+3.993
5Y10.7446.122+4.622
10Y8.8096.434+2.375
1.3.2. Quick Ratio

Measures if Uniqure is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Uniqure to the Biotechnology industry mean.
  • A Quick Ratio of 13.55 means the company can pay off $13.55 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Uniqure NV:

  • The MRQ is 13.554. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 12.647. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ13.554TTM12.647+0.907
TTM12.647YOY9.406+3.241
TTM12.6475Y11.300+1.347
5Y11.30010Y9.051+2.249
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.5543.504+10.050
TTM12.6473.991+8.656
YOY9.4065.371+4.035
5Y11.3006.088+5.212
10Y9.0516.395+2.656

1.4. Solvency of Uniqure NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Uniqure assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Uniqure to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.75 means that Uniqure assets are financed with 75.0% credit (debt) and the remaining percentage (100% - 75.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Uniqure NV:

  • The MRQ is 0.750. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.603. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.750TTM0.603+0.147
TTM0.603YOY0.312+0.291
TTM0.6035Y0.370+0.234
5Y0.37010Y0.464-0.094
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7500.339+0.411
TTM0.6030.337+0.266
YOY0.3120.271+0.041
5Y0.3700.368+0.002
10Y0.4640.388+0.076
1.4.2. Debt to Equity Ratio

Measures if Uniqure is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Uniqure to the Biotechnology industry mean.
  • A Debt to Equity ratio of 300.5% means that company has $3.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Uniqure NV:

  • The MRQ is 3.005. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.861. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ3.005TTM1.861+1.144
TTM1.861YOY0.456+1.405
TTM1.8615Y0.746+1.115
5Y0.74610Y1.285-0.539
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0050.392+2.613
TTM1.8610.403+1.458
YOY0.4560.335+0.121
5Y0.7460.427+0.319
10Y1.2850.461+0.824

2. Market Valuation of Uniqure NV

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Uniqure generates.

  • Above 15 is considered overpriced but always compare Uniqure to the Biotechnology industry mean.
  • A PE ratio of -1.11 means the investor is paying $-1.11 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Uniqure NV:

  • The EOD is -0.742. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.106. Based on the earnings, the company is expensive. -2
  • The TTM is -1.781. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.742MRQ-1.106+0.364
MRQ-1.106TTM-1.781+0.675
TTM-1.781YOY6.201-7.982
TTM-1.7815Y-36.336+34.556
5Y-36.33610Y-23.419-12.918
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.742-2.300+1.558
MRQ-1.106-2.656+1.550
TTM-1.781-2.718+0.937
YOY6.201-4.145+10.346
5Y-36.336-6.258-30.078
10Y-23.419-6.315-17.104
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Uniqure NV:

  • The EOD is -1.053. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.570. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.190. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.053MRQ-1.570+0.517
MRQ-1.570TTM-1.190-0.380
TTM-1.190YOY-6.759+5.569
TTM-1.1905Y-11.046+9.856
5Y-11.04610Y-13.710+2.664
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.053-2.974+1.921
MRQ-1.570-3.306+1.736
TTM-1.190-3.508+2.318
YOY-6.759-5.613-1.146
5Y-11.046-8.378-2.668
10Y-13.710-8.873-4.837
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Uniqure is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.56 means the investor is paying $1.56 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Uniqure NV:

  • The EOD is 1.046. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.560. Based on the equity, the company is underpriced. +1
  • The TTM is 1.660. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.046MRQ1.560-0.514
MRQ1.560TTM1.660-0.100
TTM1.660YOY1.956-0.296
TTM1.6605Y6.059-4.399
5Y6.05910Y9.884-3.824
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0461.914-0.868
MRQ1.5602.116-0.556
TTM1.6602.097-0.437
YOY1.9562.881-0.925
5Y6.0593.550+2.509
10Y9.8843.936+5.948
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Uniqure NV.

3.1. Institutions holding Uniqure NV

Institutions are holding 81.728% of the shares of Uniqure NV.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Nantahala Capital Management, LLC12.36681.19795916054289225595.6497
2023-12-31Vestal Point Capital LP8.20472.815392500039250000
2023-12-31State Street Corporation7.27220.00123478872285900.8286
2023-12-31BlackRock Inc3.83940.000318366961054806.0928
2023-12-31Morgan Stanley - Brokerage Accounts3.67870.00111759818-921591-34.3697
2023-12-31683 Capital Management LLC3.5390.938716930001180007.4921
2023-12-31Goldman Sachs Group Inc2.90710.00081390690928871201.1331
2023-12-31Orbimed Advisors, LLC2.81760.18221347900-716555-34.7092
2023-12-31Pictet Asset Manangement SA2.76820.0099132424632055231.9372
2023-09-30International Biotechnology Trust PLC2.59522.8063124150012260007909.6774
2023-12-31Schroder Investment Management Group2.59520.0109124150012415000
2023-12-31Vanguard Group Inc2.01260.000196279693600.9817
2023-09-30TANG CAPITAL MANAGEMENT LLC1.95620.8869358009358000
2023-12-31Ameriprise Financial Inc1.71470.0017820260445795119.0485
2023-12-31JPMorgan Chase & Co1.56640.000574935415643326.3834
2023-12-31Citigroup Inc1.55510.0036743910-22611-2.9498
2023-12-31BNP Paribas Arbitrage, SA1.47720.0054706670448319173.531
2023-12-31Macquarie Group Ltd1.47620.005570616600
2023-09-30Citadel Advisors Llc1.13280.0008541912-114226-17.4088
2023-12-31Geode Capital Management, LLC1.00270.0003479675314437.0149
Total 66.4788.868231801819+11038415+34.7%

3.2. Funds holding Uniqure NV

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Worldwide Healthcare Ord2.81760.3649134790000
2024-01-31International Biotechnology Ord2.59522.0887124150000
2024-02-29Delaware Healthcare I1.47620.520970616600
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.38160.0037660917-1002-0.1514
2024-02-29JPM Thematics Genetic Thrps C2 Acc USD1.17290.4231561093-8489-1.4904
2023-12-31Columbia Small Cap Value I1.10510.2622528660292650123.999
2024-02-29Columbia Small Cap Value I A1.10430.2282528260-4100-0.7702
2023-10-13Pictet Biopharmaceutical Mother1.04350.216249920017952056.1562
2023-12-31AlphaCentric LifeSci Healthcare I0.88012.7345421025295257.5415
2024-03-28iShares Biotechnology ETF0.68010.022232534500
2024-02-29abrdn Healthcare Investors0.51020.140124408600
2024-03-29Schwab US Small-Cap ETF™0.44180.006421135600
2024-02-29Columbia VP Small Cap Value 10.43780.227120943000
2024-02-29Fidelity Extended Market Index0.41510.003198555-49649-20.0033
2024-02-29abrdn Life Sciences Investors0.32690.203315639400
2024-02-29Vanguard Health Care ETF0.30610.0041464117520.5163
2023-12-31Vanguard Strategic Small-Cap Equity Inv0.29450.064114087700
2024-03-31BlackRock Extended Equity Market K0.22390.0038107095390.0364
2023-09-30BlackRock Extended Mkt Composite0.21260.004810170600
2024-03-28Invesco FTSE RAFI US 1500 Small-Mid ETF0.2090.02189996400
Total 17.63457.5438435940+439246+5.2%

3.3. Insider Transactions

Insiders are holding 9.884% of the shares of Uniqure NV.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-26Christian KlemtSELL159066.38
2024-02-26Matthew C KapustaSELL279046.35
2024-02-26Pierre CalozSELL94556.47
2023-09-18Ricardo DolmetschSELL58417.46
2023-07-10Pierre CalozSELL1511711.36
2023-06-16Christian KlemtSELL158718.94
2023-06-16Pierre CalozSELL292018.8
2023-06-16Rachelle Suzanne JacquesSELL230118.76

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Uniqure NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.278-1.402+10%-0.626-51%0.029-4455%0.105-1322%
Book Value Per Share--4.3416.493-33%10.084-57%7.542-42%4.770-9%
Current Ratio--8.8489.176-4%9.330-5%10.744-18%8.809+0%
Debt To Asset Ratio--0.7500.603+24%0.312+140%0.370+103%0.464+62%
Debt To Equity Ratio--3.0051.861+61%0.456+559%0.746+303%1.285+134%
Dividend Per Share----0%-0%-0%-0%
Eps---1.530-1.612+5%-0.663-57%-0.371-76%-0.488-68%
Free Cash Flow Per Share---1.078-0.800-26%-0.851-21%-0.308-71%-0.300-72%
Free Cash Flow To Equity Per Share---1.0771.096-198%-0.843-22%0.439-345%0.279-486%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---16.458--------
Intrinsic Value_10Y_min---20.994--------
Intrinsic Value_1Y_max---0.509--------
Intrinsic Value_1Y_min---1.362--------
Intrinsic Value_3Y_max---2.399--------
Intrinsic Value_3Y_min---4.758--------
Intrinsic Value_5Y_max---5.336--------
Intrinsic Value_5Y_min---8.860--------
Market Cap217185882.000-49%323865291.000539137641.000-40%934521190.500-65%1566106346.250-79%1191723810.450-73%
Net Profit Margin---10.944-29.345+168%-34.401+214%-38.319+250%-22.513+106%
Operating Margin---8.160-26.915+230%-46.945+475%-43.379+432%-24.820+204%
Operating Ratio--10.23128.055-64%46.949-78%47.604-79%30.074-66%
Pb Ratio1.046-49%1.5601.660-6%1.956-20%6.059-74%9.884-84%
Pe Ratio-0.742+33%-1.106-1.781+61%6.201-118%-36.336+3185%-23.419+2017%
Price Per Share4.540-49%6.77011.270-40%19.535-65%32.738-79%24.912-73%
Price To Free Cash Flow Ratio-1.053+33%-1.570-1.190-24%-6.759+331%-11.046+604%-13.710+773%
Price To Total Gains Ratio-3.554+33%-5.299-8.388+58%-6.578+24%-24.341+359%-19.371+266%
Quick Ratio--13.55412.647+7%9.406+44%11.300+20%9.051+50%
Return On Assets---0.088-0.096+10%-0.046-48%-0.046-48%-0.069-21%
Return On Equity---0.353-0.267-24%-0.066-81%-0.102-71%-0.196-44%
Total Gains Per Share---1.278-1.402+10%-0.626-51%0.029-4455%0.105-1322%
Usd Book Value--207670000.000310636250.000-33%482417000.000-57%360797500.000-42%228211239.541-9%
Usd Book Value Change Per Share---1.278-1.402+10%-0.626-51%0.029-4455%0.105-1322%
Usd Book Value Per Share--4.3416.493-33%10.084-57%7.542-42%4.770-9%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.530-1.612+5%-0.663-57%-0.371-76%-0.488-68%
Usd Free Cash Flow---51579000.000-38270750.000-26%-40687000.000-21%-14747650.000-71%-14344441.714-72%
Usd Free Cash Flow Per Share---1.078-0.800-26%-0.851-21%-0.308-71%-0.300-72%
Usd Free Cash Flow To Equity Per Share---1.0771.096-198%-0.843-22%0.439-345%0.279-486%
Usd Market Cap217185882.000-49%323865291.000539137641.000-40%934521190.500-65%1566106346.250-79%1191723810.450-73%
Usd Price Per Share4.540-49%6.77011.270-40%19.535-65%32.738-79%24.912-73%
Usd Profit---73206000.000-77119500.000+5%-31697250.000-57%-17745150.000-76%-17566671.414-76%
Usd Revenue--6689000.0003960750.000+69%26620750.000-75%34556150.000-81%18904376.476-65%
Usd Total Gains Per Share---1.278-1.402+10%-0.626-51%0.029-4455%0.105-1322%
 EOD+3 -5MRQTTM+17 -16YOY+8 -255Y+7 -2610Y+8 -25

4.2. Fundamental Score

Let's check the fundamental score of Uniqure NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.742
Price to Book Ratio (EOD)Between0-11.046
Net Profit Margin (MRQ)Greater than0-10.944
Operating Margin (MRQ)Greater than0-8.160
Quick Ratio (MRQ)Greater than113.554
Current Ratio (MRQ)Greater than18.848
Debt to Asset Ratio (MRQ)Less than10.750
Debt to Equity Ratio (MRQ)Less than13.005
Return on Equity (MRQ)Greater than0.15-0.353
Return on Assets (MRQ)Greater than0.05-0.088
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Uniqure NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.659
Ma 20Greater thanMa 504.923
Ma 50Greater thanMa 1005.290
Ma 100Greater thanMa 2005.849
OpenGreater thanClose4.490
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  101,095-98,2052,890-1,8201,070-669401-2,547-2,146



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets831,689
Total Liabilities624,019
Total Stockholder Equity207,670
 As reported
Total Liabilities 624,019
Total Stockholder Equity+ 207,670
Total Assets = 831,689

Assets

Total Assets831,689
Total Current Assets651,853
Long-term Assets179,836
Total Current Assets
Cash And Cash Equivalents 241,360
Short-term Investments 376,532
Net Receivables 4,193
Inventory 12,024
Other Current Assets 2,655
Total Current Assets  (as reported)651,853
Total Current Assets  (calculated)636,764
+/- 15,089
Long-term Assets
Property Plant Equipment 75,337
Goodwill 26,379
Intangible Assets 60,481
Long-term Assets Other 5,363
Long-term Assets  (as reported)179,836
Long-term Assets  (calculated)167,560
+/- 12,276

Liabilities & Shareholders' Equity

Total Current Liabilities73,675
Long-term Liabilities550,344
Total Stockholder Equity207,670
Total Current Liabilities
Short-term Debt 8,344
Accounts payable 6,586
Other Current Liabilities 29,648
Total Current Liabilities  (as reported)73,675
Total Current Liabilities  (calculated)44,578
+/- 29,097
Long-term Liabilities
Long term Debt 101,749
Capital Lease Obligations 36,660
Long-term Liabilities Other 412,736
Long-term Liabilities  (as reported)550,344
Long-term Liabilities  (calculated)551,145
+/- 801
Total Stockholder Equity
Common Stock2,883
Retained Earnings -890,409
Accumulated Other Comprehensive Income -53,553
Other Stockholders Equity 1,148,749
Total Stockholder Equity (as reported)207,670
Total Stockholder Equity (calculated)207,670
+/-0
Other
Capital Stock2,883
Cash and Short Term Investments 617,892
Common Stock Shares Outstanding 47,834
Current Deferred Revenue29,097
Liabilities and Stockholders Equity 831,689
Net Debt -102,951
Net Invested Capital 309,419
Net Working Capital 578,178
Property Plant and Equipment Gross 131,009
Short Long Term Debt Total 138,409



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302011-12-31
> Total Assets 
7,530
0
7,362
0
45,995
58,930
53,811
53,811
138,781
128,582
116,477
116,477
258,461
286,535
264,691
264,691
231,165
213,988
190,265
169,635
157,965
138,986
209,644
192,238
308,539
281,060
273,906
268,994
253,078
471,592
448,630
414,243
385,341
350,507
340,395
363,853
784,264
774,625
809,180
757,150
701,211
638,234
704,964
631,004
942,769
871,550
831,689
831,689871,550942,769631,004704,964638,234701,211757,150809,180774,625784,264363,853340,395350,507385,341414,243448,630471,592253,078268,994273,906281,060308,539192,238209,644138,986157,965169,635190,265213,988231,165264,691264,691286,535258,461116,477116,477128,582138,78153,81153,81158,93045,99507,36207,530
   > Total Current Assets 
0
0
1,460
337
36,643
46,731
38,191
38,191
104,300
84,569
69,783
69,783
210,414
250,034
229,035
229,035
192,107
168,433
143,946
123,729
111,425
92,315
162,783
145,470
262,706
242,080
236,576
213,195
188,541
407,642
384,206
349,601
319,635
287,380
258,911
282,330
694,224
593,764
628,239
578,212
523,299
464,577
476,774
442,643
756,959
693,626
651,853
651,853693,626756,959442,643476,774464,577523,299578,212628,239593,764694,224282,330258,911287,380319,635349,601384,206407,642188,541213,195236,576242,080262,706145,470162,78392,315111,425123,729143,946168,433192,107229,035229,035250,034210,41469,78369,78384,569104,30038,19138,19146,73136,6433371,46000
       Cash And Cash Equivalents 
1,427
0
348
-337
12,476
42,408
32,879
32,879
98,307
79,665
64,715
64,715
203,969
241,349
222,522
222,522
184,254
157,435
132,496
120,271
104,087
88,934
159,371
140,822
259,180
239,546
234,898
208,787
184,095
403,163
377,793
342,029
314,265
279,493
244,932
260,813
677,330
578,464
556,256
524,886
500,524
440,313
228,012
153,851
513,598
229,484
241,360
241,360229,484513,598153,851228,012440,313500,524524,886556,256578,464677,330260,813244,932279,493314,265342,029377,793403,163184,095208,787234,898239,546259,180140,822159,37188,934104,087120,271132,496157,435184,254222,522222,522241,349203,96964,71564,71579,66598,30732,87932,87942,40812,476-33734801,427
       Short-term Investments 
0
0
0
674
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124,831
161,487
114,989
429,428
376,532
376,532429,428114,989161,487124,83100000000000000000000000000000000000000674000
       Net Receivables 
0
0
1,112
0
22,950
3,747
3,578
3,578
4,516
3,129
4,199
4,199
4,605
6,806
5,345
5,345
7,449
10,919
9,180
1,750
5,817
1,945
1,586
1,057
1,037
552
233
461
355
101
947
258
222
223
6,618
5,445
2,705
3,771
58,768
38,644
3,119
3,603
102,376
104,793
102,559
1,644
4,193
4,1931,644102,559104,793102,3763,6033,11938,64458,7683,7712,7055,4456,6182232222589471013554612335521,0371,0571,5861,9455,8171,7509,18010,9197,4495,3455,3456,8064,6054,1994,1993,1294,5163,5783,5783,74722,95001,11200
       Other Current Assets 
0
0
0
0
974
0
540
540
895
1,091
626
626
1,375
1,417
692
692
0
6,902
1,274
579
632
747
687
1,603
418
312
329
350
580
558
748
1,576
1,066
3,496
3,024
6,886
3,328
1,184
2,675
2,260
1,581
2,894
2,814
2,468
3,250
2,532
2,655
2,6552,5323,2502,4682,8142,8941,5812,2602,6751,1843,3286,8863,0243,4961,0661,5767485585803503293124181,6036877476325791,2746,90206926921,4171,3756266261,09189554054009740000
   > Long-term Assets 
0
0
5,902
0
9,352
12,199
15,620
15,620
34,481
44,013
46,694
46,694
48,047
36,500
35,656
35,656
39,059
45,555
46,319
45,906
46,540
46,671
46,861
46,768
45,833
38,980
37,330
55,799
64,537
63,950
64,424
64,642
65,706
63,127
81,484
81,523
90,040
180,861
180,941
178,938
177,912
173,657
228,190
188,361
185,810
177,924
179,836
179,836177,924185,810188,361228,190173,657177,912178,938180,941180,86190,04081,52381,48463,12765,70664,64264,42463,95064,53755,79937,33038,98045,83346,76846,86146,67146,54045,90646,31945,55539,05935,65635,65636,50048,04746,69446,69444,01334,48115,62015,62012,1999,35205,90200
       Property Plant Equipment 
1,161
0
1,567
0
1,625
1,826
3,610
3,610
19,938
21,641
23,915
23,915
24,654
25,460
26,042
26,042
26,742
33,354
35,702
35,241
35,410
34,653
34,281
33,839
32,126
30,802
29,179
46,456
55,230
55,130
55,568
54,024
55,440
55,843
58,414
59,175
65,153
67,409
69,078
69,859
74,466
75,690
83,258
82,207
79,962
76,306
75,337
75,33776,30679,96282,20783,25875,69074,46669,85969,07867,40965,15359,17558,41455,84355,44054,02455,56855,13055,23046,45629,17930,80232,12633,83934,28134,65335,41035,24135,70233,35426,74226,04226,04225,46024,65423,91523,91521,64119,9383,6103,6101,8261,62501,56701,161
       Goodwill 
0
0
0
0
0
0
0
0
0
1,703
1,632
1,632
1,505
1,510
483
483
492
496
465
471
505
522
530
545
516
513
506
496
503
482
496
486
496
518
542
518
525
28,060
27,633
26,565
24,976
23,418
25,581
25,998
26,016
25,273
26,379
26,37925,27326,01625,99825,58123,41824,97626,56527,63328,0605255185425184964864964825034965065135165455305225054714654964924834831,5101,5051,6321,6321,703000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,984
0
0
0
0
000039,984000000000000000000000000000000000000000000
       Intangible Assets 
0
0
4,335
0
7,727
9,135
10,736
10,736
13,272
19,428
19,904
19,904
20,632
8,284
7,882
7,882
9,962
9,840
8,324
8,357
8,746
9,027
9,570
9,884
10,733
5,211
5,201
5,917
5,864
5,424
5,427
7,211
7,087
4,052
3,361
2,908
2,637
64,005
62,686
61,135
57,450
53,837
58,778
59,704
59,713
57,976
60,481
60,48157,97659,71359,70458,77853,83757,45061,13562,68664,0052,6372,9083,3614,0527,0877,2115,4275,4245,8645,9175,2015,21110,7339,8849,5709,0278,7468,3578,3249,8409,9627,8827,8828,28420,63219,90419,90419,42813,27210,73610,7369,1357,72704,33500
       Long-term Assets Other 
0
0
0
0
-9,352
1,237
1,275
1,275
1,272
1,241
1,243
1,243
1,256
1,247
1,249
1,249
1,863
1,866
1,828
1,837
1,879
2,469
2,480
2,500
2,458
2,454
2,444
2,930
2,940
2,914
2,933
2,921
2,683
2,714
2,748
2,716
5,760
5,668
5,897
5,937
2,832
2,979
6,061
2,948
6,124
6,018
5,363
5,3636,0186,1242,9486,0612,9792,8325,9375,8975,6685,7602,7162,7482,7142,6832,9212,9332,9142,9402,9302,4442,4542,4582,5002,4802,4691,8791,8371,8281,8661,8631,2491,2491,2471,2561,2431,2431,2411,2721,2751,2751,237-9,3520000
> Total Liabilities 
0
0
7,955
0
62,120
43,653
46,128
46,128
63,320
63,608
64,086
64,086
126,755
139,747
134,059
134,059
136,277
132,784
126,634
123,908
130,679
119,379
120,285
91,975
90,123
81,208
94,300
111,882
121,022
121,360
125,572
119,096
119,836
122,614
96,490
135,163
150,656
183,870
213,404
211,149
214,723
217,064
228,955
218,233
589,449
602,766
624,019
624,019602,766589,449218,233228,955217,064214,723211,149213,404183,870150,656135,16396,490122,614119,836119,096125,572121,360121,022111,88294,30081,20890,12391,975120,285119,379130,679123,908126,634132,784136,277134,059134,059139,747126,75564,08664,08663,60863,32046,12846,12843,65362,12007,95500
   > Total Current Liabilities 
4,766
0
7,360
0
31,246
11,899
14,433
14,433
15,294
14,015
14,923
14,923
25,072
26,982
26,653
26,653
24,261
22,966
22,721
20,473
23,130
25,374
19,230
26,557
31,440
32,011
19,969
22,418
23,368
28,447
31,630
27,128
29,840
33,350
27,334
32,102
46,095
41,917
36,763
44,700
48,261
63,974
75,919
66,336
68,356
68,607
73,675
73,67568,60768,35666,33675,91963,97448,26144,70036,76341,91746,09532,10227,33433,35029,84027,12831,63028,44723,36822,41819,96932,01131,44026,55719,23025,37423,13020,47322,72122,96624,26126,65326,65326,98225,07214,92314,92314,01515,29414,43314,43311,89931,24607,36004,766
       Short-term Debt 
0
0
0
0
0
368
1,174
1,174
236
690
829
829
4,588
6,237
6,495
6,495
715
716
605
2,443
4,319
6,232
1,050
4,444
8,028
11,111
7,998
3,808
4,256
4,436
5,865
5,900
5,495
5,552
5,524
5,457
5,752
5,798
5,774
5,754
6,505
6,434
8,382
7,669
7,780
7,888
8,344
8,3447,8887,7807,6698,3826,4346,5055,7545,7745,7985,7525,4575,5245,5525,4955,9005,8654,4364,2563,8087,99811,1118,0284,4441,0506,2324,3192,4436057167156,4956,4956,2374,5888298296902361,1741,17436800000
       Short Long Term Debt 
0
0
0
0
0
0
7,600
0
0
0
251
0
0
0
5,579
0
18,000
20,555
605
2,443
20,472
6,232
1,050
4,444
8,028
11,111
0
3,808
4,256
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000004,2563,808011,1118,0284,4441,0506,23220,4722,44360520,55518,00005,5790002510007,600000000
       Accounts payable 
2,253
0
2,776
0
3,123
4,315
4,843
4,843
6,849
5,069
5,910
5,910
11,703
5,591
4,193
4,193
13,980
13,101
5,524
3,954
3,458
2,987
2,908
3,695
3,866
4,115
3,792
3,527
4,523
3,782
5,681
4,989
4,942
2,348
3,772
5,749
16,817
5,373
2,502
9,920
10,028
7,566
10,984
8,885
9,373
5,584
6,586
6,5865,5849,3738,88510,9847,56610,0289,9202,5025,37316,8175,7493,7722,3484,9424,9895,6813,7824,5233,5273,7924,1153,8663,6952,9082,9873,4583,9545,52413,10113,9804,1934,1935,59111,7035,9105,9105,0696,8494,8434,8434,3153,12302,77602,253
       Other Current Liabilities 
2,460
0
4,584
0
28,123
5,759
6,650
6,650
6,377
6,600
6,569
6,569
3,883
9,439
9,159
9,159
2,917
2,897
10,450
7,851
10,150
11,906
10,659
8,722
11,083
8,191
545
7,311
7,366
12,702
12,457
9,507
13,250
17,784
15,956
15,896
23,526
30,746
28,487
29,026
16,533
36,477
45,433
38,853
27,666
26,708
29,648
29,64826,70827,66638,85345,43336,47716,53329,02628,48730,74623,52615,89615,95617,78413,2509,50712,45712,7027,3667,3115458,19111,0838,72210,65911,90610,1507,85110,4502,8972,9179,1599,1599,4393,8836,5696,5696,6006,3776,6506,6505,75928,12304,58402,460
   > Long-term Liabilities 
0
0
595
0
9,425
31,754
31,695
31,695
48,026
49,593
49,163
49,163
101,682
112,764
107,406
107,406
112,015
109,818
103,913
103,435
107,549
94,005
101,055
65,418
58,683
49,197
74,331
89,464
97,654
92,913
93,942
91,968
89,996
89,264
69,156
103,061
104,561
141,953
176,641
166,449
166,462
153,090
153,036
151,897
521,093
534,159
550,344
550,344534,159521,093151,897153,036153,090166,462166,449176,641141,953104,561103,06169,15689,26489,99691,96893,94292,91397,65489,46474,33149,19758,68365,418101,05594,005107,549103,435103,913109,818112,015107,406107,406112,764101,68249,16349,16349,59348,02631,69531,69531,7549,425059500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,471
35,630
35,784
35,928
36,062
36,209
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000036,20936,06235,92835,78435,63035,47100000000000000000000000000
       Other Liabilities 
0
0
0
0
0
21,520
22,540
26,167
28,044
27,582
27,226
24,370
82,698
95,497
92,091
94,811
90,845
89,501
84,282
85,515
91,396
79,652
81,314
49,049
45,843
39,600
38,860
30,490
30,000
25,743
26,747
25,241
24,344
23,437
3,136
3,107
3,247
40,730
46,691
0
33,851
20,803
18,526
0
0
403,751
0
0403,7510018,52620,80333,851046,69140,7303,2473,1073,13623,43724,34425,24126,74725,74330,00030,49038,86039,60045,84349,04981,31479,65291,39685,51584,28289,50190,84594,81192,09195,49782,69824,37027,22627,58228,04426,16722,54021,52000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
8,244
0
0
0
89,692
0
0
396
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000003960089,6920008,2440000000000
> Total Stockholder Equity
0
0
-592
-574
-16,125
15,277
7,683
7,683
75,462
64,974
52,391
52,391
131,707
146,788
130,632
130,632
94,889
81,204
63,631
45,727
27,286
19,607
89,359
100,263
218,416
199,852
179,606
157,112
132,056
350,232
323,058
295,147
265,505
227,893
243,905
228,690
633,608
590,755
595,776
546,001
486,488
421,170
476,009
412,771
353,320
268,784
207,670
207,670268,784353,320412,771476,009421,170486,488546,001595,776590,755633,608228,690243,905227,893265,505295,147323,058350,232132,056157,112179,606199,852218,416100,26389,35919,60727,28645,72763,63181,20494,889130,632130,632146,788131,70752,39152,39164,97475,4627,6837,68315,277-16,125-574-59200
   Retained Earnings -890,409-817,203-727,632-659,158-581,931-588,738-540,881-501,820-455,142-463,350-426,819-826,287-784,731-784,032-730,257-687,706-659,707-618,281-594,677-563,278-535,506-513,618-491,583-470,991-475,318-447,844-437,599-416,330-396,058-343,283-325,322-276,126-276,126-268,304-238,460-220,197-220,197-215,613-219,477-198,902-198,902-185,753-169,9410-155,04300
   Accumulated Other Comprehensive Income 
0
0
1,994
0
0
7,994
9,025
9,025
15,228
18,300
20,853
20,853
24,284
26,237
28,454
28,454
33,131
34,061
-6,557
-6,235
-5,831
-5,809
-3,800
-1,312
-4,688
-5,487
-7,259
-9,727
-8,518
-14,682
-6,689
-11,966
-7,319
2,333
9,907
2,347
-4,595
-17,883
-28,856
-39,306
-67,630
-93,000
-58,291
-52,494
-52,440
-58,558
-53,553
-53,553-58,558-52,440-52,494-58,291-93,000-67,630-39,306-28,856-17,883-4,5952,3479,9072,333-7,319-11,966-6,689-14,682-8,518-9,727-7,259-5,487-4,688-1,312-3,800-5,809-5,831-6,235-6,55734,06133,13128,45428,45426,23724,28420,85320,85318,30015,2289,0259,0257,994001,99400
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
464,653
466,688
469,104
0
0
570,595
712,399
716,663
720,072
727,795
732,924
980,549
986,803
992,136
1,000,389
1,006,898
1,016,018
1,049,850
1,062,234
1,069,191
1,076,972
1,084,306
1,092,176
1,100,078
0
1,121,554
1,130,515
0
0
001,130,5151,121,55401,100,0781,092,1761,084,3061,076,9721,069,1911,062,2341,049,8501,016,0181,006,8981,000,389992,136986,803980,549732,924727,795720,072716,663712,399570,59500469,104466,688464,653000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue15,843
Cost of Revenue-13,628
Gross Profit2,2152,215
 
Operating Income (+$)
Gross Profit2,215
Operating Expense-285,086
Operating Income-282,871-282,871
 
Operating Expense (+$)
Research Development214,864
Selling General Administrative75,360
Selling And Marketing Expenses0
Operating Expense285,086290,224
 
Net Interest Income (+$)
Interest Income12,885
Interest Expense-41,557
Other Finance Cost-12,286
Net Interest Income-16,386
 
Pretax Income (+$)
Operating Income-282,871
Net Interest Income-16,386
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-306,557-281,180
EBIT - interestExpense = -304,866
-306,557
-266,921
Interest Expense41,557
Earnings Before Interest and Taxes (EBIT)-263,309-265,000
Earnings Before Interest and Taxes (EBITDA)-251,409
 
After tax Income (+$)
Income Before Tax-306,557
Tax Provision--1,320
Net Income From Continuing Ops-228,465-305,237
Net Income-308,478
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses298,714
Total Other Income/Expenses Net-1,69116,386
 

Technical Analysis of Uniqure
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Uniqure. The general trend of Uniqure is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Uniqure's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Uniqure NV.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.76 < 5.4799 < 6.87.

The bearish price targets are: .

Tweet this
Uniqure NV Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Uniqure NV. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Uniqure NV Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Uniqure NV. The current macd is -0.1913009.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Uniqure price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Uniqure. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Uniqure price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Uniqure NV Daily Moving Average Convergence/Divergence (MACD) ChartUniqure NV Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Uniqure NV. The current adx is 14.12.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Uniqure shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Uniqure NV Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Uniqure NV. The current sar is 5.02719178.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Uniqure NV Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Uniqure NV. The current rsi is 34.66. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Uniqure NV Daily Relative Strength Index (RSI) ChartUniqure NV Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Uniqure NV. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Uniqure price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Uniqure NV Daily Stochastic Oscillator ChartUniqure NV Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Uniqure NV. The current cci is -122.07453109.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Uniqure NV Daily Commodity Channel Index (CCI) ChartUniqure NV Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Uniqure NV. The current cmo is -39.52051911.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Uniqure NV Daily Chande Momentum Oscillator (CMO) ChartUniqure NV Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Uniqure NV. The current willr is -80.20833333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Uniqure NV Daily Williams %R ChartUniqure NV Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Uniqure NV.

Uniqure NV Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Uniqure NV. The current atr is 0.23921653.

Uniqure NV Daily Average True Range (ATR) ChartUniqure NV Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Uniqure NV. The current obv is -26,734,862.

Uniqure NV Daily On-Balance Volume (OBV) ChartUniqure NV Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Uniqure NV. The current mfi is 26.93.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Uniqure NV Daily Money Flow Index (MFI) ChartUniqure NV Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Uniqure NV.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Uniqure NV Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Uniqure NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.659
Ma 20Greater thanMa 504.923
Ma 50Greater thanMa 1005.290
Ma 100Greater thanMa 2005.849
OpenGreater thanClose4.490
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Uniqure with someone you think should read this too:
  • Are you bullish or bearish on Uniqure? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Uniqure? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Uniqure NV

I send you an email if I find something interesting about Uniqure NV.


Comments

How you think about this?

Leave a comment

Stay informed about Uniqure NV.

Receive notifications about Uniqure NV in your mailbox!